Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 first quarter earnings conference call on Monday, May 11, 2026 at 8:30 a.m. ET. Cronos’ senior management ...

Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway has been selected by Health PEI, the agency delivering publicly-funded ...

James Treat, MD, Professor of Clinical Pediatrics and Dermatology at the Children’s Hospital of Philadelphia to present clinical results on Wednesday, May 20, 2026, at 4:30 p.m. ET WAYNE, Pa., April ...

Through its investment in and collaboration with PsyLabs, the Company has established a GMP-compliant, pharmaceutical-grade supply chain NEW YORK, April 20, 2026 (GLOBE NEWSWIRE)-- Psyence Biomedical ...

ALP” for Alpha Represents The Company’s Strategic Focus on Scalable, AI Confidential Computing Infrastructure, leaning into its success with AI Confidential Computing for Telegram and other Clients ...

Order reflects growing adoption of lithium-based idle reduction systems across commercial heavy-duty trucking fleets Purchase order valued at over $3 million from Stevens Transport, spanning nearly ...

The Iran conflict and disruption risks in the Strait of Hormuz have prompted renewed scrutiny of the Taiwan Strait as a ...

Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation ...

HALIFAX, Nova Scotia, April 20, 2026 (GLOBE NEWSWIRE)-- Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN; OTCQX: ERDCF) ( ...

China’s Liaoning aircraft carrier transited the Taiwan Strait, Taiwan’s Ministry of National Defense said Monday. The Eastern ...

Helium Evolution Incorporated (TSXV:HEVI) ("HEVI" or the "Company"), a Canadian-based helium exploration company focused on de ...

Rare Pediatric Disease Designation may render Pasithea eligible to receive a Priority Review Voucher (PRV) MIAMI, April 20, 2026 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (N ...